10.3 C
London
Sunday, February 23, 2025
HomeMarketsEurope Markets

Europe Markets

spot_img

Rapamune | European Medicines Agency (EMA)

OverviewRapamune is a medicine used to prevent the body from rejecting a newly transplanted kidney. It is used in adults who are at...

Alkindi | European Medicines Agency (EMA)

OverviewThis is a summary of the European public assessment report (EPAR) for Alkindi. It explains how the Agency assessed the medicine to recommend...

Cejemly | European Medicines Agency (EMA)

OverviewCejemly is a cancer medicine used in adults to treat a lung cancer called non-small cell lung cancer (NSCLC) that has spread to...

Hepcludex | European Medicines Agency (EMA)

OverviewHepcludex is an antiviral medicine used to treat chronic (long-term) hepatitis delta virus (HDV) infection in adults and children from 3 years of...

Fortacin | European Medicines Agency (EMA)

OverviewFortacin is used to treat men with primary (lifelong) premature ejaculation (when ejaculation regularly occurs before, or too early during, penetration).Fortacin contains the...

Trazimera | European Medicines Agency (EMA)

OverviewTrazimera is a cancer medicine used to treat the following conditions:early breast cancer (when the cancer has spread within the breast or to...

Obizur | European Medicines Agency (EMA)

OverviewThis is a summary of the European public assessment report (EPAR) for Obizur. It explains how the Agency assessed the medicine to recommend...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read

spot_img